Prestwick Pharmaceuticals

About:

Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases.

Top Investors: Warburg Pincus, Sofinnova Investments, Scale Venture Partners, Atlas Venture, Vivo Capital

Description:

Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.